help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on April 26, 2007, doi:10.1164/rccm.200702-270OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200702-270OCv1
176/1/10    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, J. P.
Right arrow Articles by Torres, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, J. P.
Right arrow Articles by Torres, R. M.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 10-19, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200702-270OC


Original Article

Arhgef1 Is Required by T Cells for the Development of Airway Hyperreactivity and Inflammation

Jeanette P. Brown1,*, Christian Taube2,*, Nobuaki Miyahara2, Toshiyuki Koya2, Roberta Pelanda1, Erwin W. Gelfand2 and Raul M. Torres1

1 Integrated Department of Immunology, University of Colorado at Denver and Health Sciences Center and National Jewish Medical and Research Center, Denver, Colorado; and 2 Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado

Correspondence and requests for reprints should be addressed to Raul M. Torres, Ph.D., University of Colorado and Health Sciences Center and National Jewish Research and Medical Center, 1400 Jackson Street, Denver, CO 80206. E-mail: torresr{at}njc.org

Rationale: Arhgef1 is an intracellular protein, expressed by hematopoietic cells, that regulates signaling by both G protein–coupled receptors and RhoA, and, consequently, is required for appropriate migration and adhesion of diverse leukocyte populations.

Objectives: To evaluate a possible contribution for Arhgef1 in the development of airway inflammation and airway hyperreactivity.

Methods: Arhgef1-deficient (Arhgef1–/–) and wild-type (WT) mice were sensitized and airway challenged, followed by measurement of airway responsiveness to inhaled methacholine. Inflammation was assessed by several parameters that included flow cytometric analysis and histology. Arhgef1-deficient recipients were reconstituted with WT T lymphocytes before sensitization and challenge, and again measured for airway responsiveness and inflammation. Cytokine production in response to specific antigen was measured in cultures of isolated leukocytes from lung and spleen and compared with the levels generated in lung and spleen explant cultures.

Measurements and Main Results: Arhgef1–/– mice display significantly reduced airway hyperreactivity, Th2 cytokine production, and lung inflammation, despite intact systemic immunity. After airway challenge of Arhgef1–/– mice, antigen-specific T cells were present in mutant lungs, but were found to interact with CD11c+ cells at a significantly reduced frequency. Adoptive transfer of WT T cells into Arhgef1–/– mice restored airway hyperreactivity and inflammation.

Conclusions: These data demonstrate that T cells depend on Arhgef1 to promote lung inflammation. Moreover, a deficiency in Arhgef1 results in reduced T cell–CD11c+ antigen-presenting cell interaction, and likely underscores the inability of Arhgef1–/– mice to mount an adaptive immune response to airway challenge.

Key Words: airway hyperreactivity • cytokines • lung inflammation • T cells


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Arhgef1 is an intracellular protein that has been shown to regulate migration and adhesion through its regulation of G protein–coupled receptor signaling and RhoA activation.

What This Study Adds to the Field
T lymphocytes require Arhgef1 for airway hyperreactivity and inflammation. In the absence of Arhgef1, T cells interact with antigen-presenting cells in the lungs at a reduced frequency.

 



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
W. C. Moore
Update in Asthma 2007
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1068 - 1073.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  ATS Par News